HOME >> MEDICINE >> NEWS
Detection of antibodies could identify MS pats who do not respond well to interferon beta

Danish research published in this week's issue of THE LANCET highlights how the detection of antibodies to interferon beta-the first choice treatment for multiple sclerosis patients-could be important in identifying patients who do not respond well to interferon beta, with implications for the provision of alternative drug therapy.

Interferon beta is the first-line treatment for relapsing-remitting multiple sclerosis, but the drug can induce neutralising antibodies against itself, which might reduce its effectiveness. Per Soelberg Sorensen from Copenhagen University Hospital, Denmark, and colleagues measured neutralising antibodies every year for up to five years among 541 patients with multiple sclerosis, randomly selected from all patients who started treatment with interferon beta in Denmark between 1996 and 1999.

The time to first relapse was substantially longer (by 244 days) for patients who were antibody-negative after one year of interferon-beta treatment compared with patients who were antibody-positive. The yearly relapse rate was increased more than 50% in patients who developed antibodies compared with those who did not.

Patients developed neutralising antibodies independent of age, sex, disease duration, and prognosis at the start of treatment. The presence of antibodies did not affect overall disease outcome.

Per Soelberg Sorensen comments: "Our findings suggest that the presence of neutralising antibodies against interferon beta reduces the clinical effect of the drug. In patients who are not doing well on interferon beta, the presence of such antibodies should prompt consideration about a change of treatment to other drug therapies such as glatiramer acetate or mitoxantrone."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
9-Oct-2003


Page: 1

Related medicine news :

1. Detection at a distance for more sensitive MRI
2. Detection of glycoprotein could indentify ovarian and uterine cancers with poor prognosis
3. Detection of bioterrorism viruses brought closer to local sites
4. Detection of glucose intolerance after heart attack
5. Detection of glucose intolerance after heart attack could identify risk of cardiovascular disease
6. Millions Of Americans With Glaucoma Could Save Sight With Early Detection, Treatment
7. Microwaves May Provide Early Detection Of Breast Cancer
8. Learning From Experience: New Pattern Recognition & Detection Helps Radiologists Analyze Digital Mammograms
9. Could autoantibodies predict future disease in healthy people?
10. Mouse antibodies thwart SARS virus
11. Autoantibodies precede disease in lupus patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... 19, 2019 , ... WEDI , the nation’s leading nonprofit authority on ... statutory advisor to the U.S. Department of Health and Human Services (HHS), today issued ... was issued following the release last week at the HIMSS Global Conference and Exhibition ...
(Date:2/19/2019)... ... 2019 , ... In one of the first research studies ... team led by a Worcester Polytechnic Institute professor found that women who experience ... weight gain during pregnancy, and weight retention after their baby is born. , ...
(Date:2/19/2019)... ... February 19, 2019 , ... Dr. Alejandro ... patients with or without a referral who are interested in full arch permanent ... Kovacs routinely places All-on-4® dental implants in Texarkana, TX, for those ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... ... opioid epidemic with town halls across the country , A partnership between Liberty ... nationwide opioid crisis, continues with its next town hall event on Tuesday, February ...
(Date:2/19/2019)... ... February 19, 2019 , ... Catalent ... solutions for drugs, biologics and consumer health products, today announced that Michael ... Bioassay Conference of the BioPharmaceutical Emerging Best Practices Association (BEBPA), taking place ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... , ... February 19, 2019 , ... ... cure for Job Syndrome by providing the scientific community with additional opportunities to ... Alain Fischer as Chief Scientific Officer of the Foundation’s Scientific Advisory Board and ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... RCH ... firms of all sizes, announces the hiring of Frank Iafrato as Director of Sales ... to deepen the firm’s sales coverage throughout the Northeast region, building upon the momentum ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... for gum disease that utilizes modern dental lasers. The Laser Assisted New Attachment ... bacteria and diseased tissue, the leading cause of gum disease. Dr. Farahmand is ...
Breaking Medicine Technology:
Cached News: